These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11177606)

  • 1. In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines.
    Bruserud O; Gjertsen BT; von Volkman HL
    J Hematother Stem Cell Res; 2000 Dec; 9(6):923-32. PubMed ID: 11177606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media.
    Bruserud O; Frostad S; Foss B
    J Hematother; 1999 Feb; 8(1):63-73. PubMed ID: 10192303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of gamma-irradiation on acute myelogenous leukemia blasts: in vitro studies of proliferation, constitutive cytokine secretion, and accessory cell function during T cell activation.
    Bruserud O; Ulvestad E
    J Hematother Stem Cell Res; 1999 Aug; 8(4):431-41. PubMed ID: 10634181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of vascular endothelial growth factor on acute myelogenous leukemia blasts.
    Foss B; Mentzoni L; Bruserud O
    J Hematother Stem Cell Res; 2001 Feb; 10(1):81-93. PubMed ID: 11276362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leptin in human acute myelogenous leukemia: studies of in vivo levels and in vitro effects on native functional leukemia blasts.
    Bruserud Ø; Huang TS; Glenjen N; Gjertsen BT; Foss B
    Haematologica; 2002 Jun; 87(6):584-95. PubMed ID: 12031914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro culture of human acute lymphoblastic leukemia (ALL) cells in serum-free media; a comparison of native ALL blasts, ALL cell lines and virus-transformed B cell lines.
    Bruserud Ø; Glenjen N; Ryningen A; Ulvestad E
    Leuk Res; 2003 May; 27(5):455-64. PubMed ID: 12620297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interleukin-13 on cytokine secretion by human acute myelogenous leukemia blasts.
    Bruserud O
    Leukemia; 1996 Sep; 10(9):1497-1503. PubMed ID: 8751469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum.
    Bruserud O; Tronstad KJ; Berge R
    J Cancer Res Clin Oncol; 2005 Jun; 131(6):377-84. PubMed ID: 15776274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia.
    Bruserud O; Tore Gjertsen B; Brustugun OT; Bassøe CF; Nesthus I; Espen Akselsen P; Bühring HJ; Pawelec G
    Leukemia; 1995 Nov; 9(11):1910-20. PubMed ID: 7475283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor (PDGF) in human acute myelogenous leukemia: PDGF receptor expression, endogenous PDGF release and responsiveness to exogenous PDGF isoforms by in vitro cultured acute myelogenous leukemia blasts.
    Foss B; Ulvestad E; Bruserud O
    Eur J Haematol; 2001 Jun; 66(6):365-76. PubMed ID: 11488935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
    Munker R; Andreeff M
    Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts.
    Bruserud Ø; Ryningen A; Wergeland L; Glenjen NI; Gjertsen BT
    Haematologica; 2004 Apr; 89(4):391-402. PubMed ID: 15075072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation.
    Bruserud O; Ulvestad E
    Cell Immunol; 2000 Nov; 206(1):36-50. PubMed ID: 11161436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro effects of native human acute myelogenous leukemia blasts on fibroblasts and osteoblasts.
    Glenjen N; Ersvaer E; Ryningen A; Bruserud Ø
    Int J Cancer; 2004 Oct; 111(6):858-67. PubMed ID: 15300797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effects of insulin-like growth factor-1 (IGF-1) on proliferation and constitutive cytokine secretion by acute myelogenous leukemia blasts.
    Frostad S; Bruserud O
    Eur J Haematol; 1999 Mar; 62(3):191-8. PubMed ID: 10089897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreaction increases or restores CD40, CD54, and/or HLA molecule expression in acute myelogenous leukemia blasts, through secretion of inflammatory cytokines: Dominant role for TNFbeta, in concert with IFNgamma.
    Eljaafari A; Van Snick J; Voisin A; Cormont F; Farre A; Bienvenu J; Bernaud J; Rigal D; Thomas X
    Leukemia; 2006 Nov; 20(11):1992-2001. PubMed ID: 16990783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro crosstalk between fibroblasts and native human acute myelogenous leukemia (AML) blasts via local cytokine networks results in increased proliferation and decreased apoptosis of AML cells as well as increased levels of proangiogenic Interleukin 8.
    Ryningen A; Wergeland L; Glenjen N; Gjertsen BT; Bruserud O
    Leuk Res; 2005 Feb; 29(2):185-96. PubMed ID: 15607368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation.
    Houtenbos I; Westers TM; Stam AG; de Gruijl TD; Scheper RJ; Ossenkoppele GJ; van de Loosdrecht AA
    Cancer Immunol Immunother; 2003 Jul; 52(7):455-62. PubMed ID: 12690520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New strategies in the treatment of acute myelogenous leukemia (AML): in vitro culture of aml cells--the present use in experimental studies and the possible importance for future therapeutic approaches.
    Bruserud O; Gjertsen BT; Foss B; Huang TS
    Stem Cells; 2001; 19(1):1-11. PubMed ID: 11209086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3.
    Hu ZB; Ma W; Zaborski M; MacLeod R; Quentmeier H; Drexler HG
    Leukemia; 1996 Jun; 10(6):1025-40. PubMed ID: 8667638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.